mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.8 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |